ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,944,839 | -23.0% | 1,406,843 | -13.6% | 0.00% | 0.0% |
| Q2 2023 | $46,702,971 | +33.0% | 1,628,416 | +11.1% | 0.00% | 0.0% |
| Q1 2023 | $35,124,343 | +42.8% | 1,465,346 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $24,599,207 | +24.2% | 1,450,425 | +8.5% | 0.00% | 0.0% |
| Q3 2022 | $19,812,000 | +5.5% | 1,336,818 | +12.0% | 0.00% | 0.0% |
| Q2 2022 | $18,787,000 | -39.6% | 1,193,656 | +3.5% | 0.00% | 0.0% |
| Q1 2022 | $31,099,000 | -26.8% | 1,153,513 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $42,458,000 | -20.2% | 1,147,222 | +3.0% | 0.00% | 0.0% |
| Q3 2021 | $53,225,000 | +33.3% | 1,113,951 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $39,926,000 | -19.3% | 1,179,841 | -1.5% | 0.00% | 0.0% |
| Q1 2021 | $49,452,000 | -3.6% | 1,197,380 | +1.3% | 0.00% | 0.0% |
| Q4 2020 | $51,292,000 | +15.3% | 1,182,382 | +14.0% | 0.00% | 0.0% |
| Q3 2020 | $44,495,000 | +9.3% | 1,037,177 | +19.1% | 0.00% | 0.0% |
| Q2 2020 | $40,708,000 | +1986.5% | 870,935 | +506.6% | 0.00% | – |
| Q1 2020 | $1,951,000 | +44.8% | 143,581 | +15.9% | 0.00% | – |
| Q4 2019 | $1,347,000 | +5.9% | 123,881 | 0.0% | 0.00% | – |
| Q3 2019 | $1,272,000 | – | 123,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |